Today's Clinical Lab - News, Editorial and Products for the Clinical Laboratory

Low adoption continues to impede the digital pathology market

Digital Pathology Market Continues to Battle Low Adoption, High Costs

Scott Wallask, BA, Imogen Fitt

Analyst Imogen Fitt highlights vendors that are pushing boundaries with new digital pathology business models

The researchers suggest that a lack of standardized sampling procedures, sample processing, and different analysis workflows used by testing companies may contribute to these discrepancies.

Direct-to-Consumer Gut Microbiome Testing Kit Results Vary Between Kits and Manufacturers

Miriam Bergeret, MSc

The accuracy of gut health tests remains uncertain and no study has systematically evaluated their performance until now

Amplified Sciences Achieves CAP Accreditation for Cutting-Edge Diagnostic Lab

Purdue University

Gold standard milestone clears the path for national expansion of PanCystPro™ assay

Biochemist and molecular biologist Gregor Dombrowsky is the lead author of the study published in Genome Medicine.

Researchers Identify ‘Fingerprint’ of Gene That Commonly Causes Congenital Heart Defects

University of Oldenburg

Discovery paves the way for diagnosis and targeted therapies

The Lednev lab uses a laser technique called Raman spectroscopy to analyze the chemical composition of materials.

Researchers Develop New Laser Technique to Test mRNA-Based Therapeutics

University at Albany

Deep-UV Raman technology enables precise mRNA measurement with minimal lipid interference

Most cell-free DNA tests aim to detect tumors by sniffing out changes in cell-free DNA that accompany malignant transformation.

Noninvasive ‘Fragmentome’ Test Expands Liquid Biopsy to Liver Cirrhosis and Other Conditions

American Association for the Advancement of Science (AAAS)

The assay builds on the clinical potential of liquid biopsy platforms and could expand this technology’s utility to detect conditions besides cancer

Pooja Ghatalia, MD, an Associate Professor in the Department of Hematology/Oncology at Fox Chase Cancer Center.

Blood Test Predicts Which Bladder Cancer Patients May Safely Skip Surgery

Temple University Health System

Positive results from the RETAIN-2 trial demonstrate that a response-adapted bladder-preservation approach involving neoadjuvant chemoimmunotherapy can be considered in select patients

Standardizing Oncology Assays: A Guide to Cell Line-Derived Reference Materials

Revvity

Identify the limitations of patient tissue controls in genetic testing and examine the verification data supporting cell line-derived standards

Move Past the Limitations of Synthetic Reference Standards in Cancer Research

Revvity

A review of cell line-derived reference standards for the investigation and molecular profiling of myeloid malignancies

Modern HIV care requires multiple diagnostic tools working in concert.

CD4 Testing: A Critical Diagnostic Tool for Advanced HIV

Devasena Gnanashanmugam, MD, Penelope Zorzi, PhD

Updated recommendations emphasize the ongoing importance of CD4 testing alongside viral load monitoring in HIV care

The draft guidance focuses on therapies that target a specific genetic, cellular or molecular abnormality and are designed to correct or modify the underlying cause of disease.

FDA Fast-Tracks Ultra-Rare Therapies with Plausible Mechanism Guidance

U.S. Food and Drug Administration

Framework enables approval of individualized genome editing and RNA-based treatments when traditional trials aren’t feasible

Clinicians are encountering patients earlier in the season with more complex and overlapping symptom profiles, underscoring the need for timely and accurate diagnostic insight.

Navigating Longer, More Complex Spring Allergy Seasons: How Labs Help Clinicians Stay Ahead

Gary Falcetano, PA

Laboratory-based specific IgE testing provides clarity, enabling earlier, more targeted interventions

The cloud-based technology allows pathologists to view and manage slides digitally and use AI to support key steps in the diagnostic process.

Labcorp Expands Digital Pathology Rollout with FDA-Cleared PathAI Platform

LabCorp

Nationwide deployment of AISight® Dx aims to support fully digital workflows and AI-assisted diagnostics across anatomic pathology labs

The reference material will help crime laboratories accurately analyze genetic evidence that has degraded or contains DNA from multiple individuals.

NIST Releases New Forensic Genetic Reference Material to Help Crime Laboratories Analyze Challenging Cases

National Institute of Standards and Technology

DNA laboratories can use the samples to help train analysts and validate forensic tests

The kit is intended to support research workflows that seek to better understand the biological mechanisms underlying disease by connecting genetic variation, gene expression, and protein-level activity.

Thermo Fisher Launches All-in-One Kit for Sequential DNA, RNA and Protein Extraction

Thermo Fisher Scientific

Integrated solution simplifies multi-layer molecular analysis, advancing precision medicine and translational research